{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:31:01Z","timestamp":1780050661670,"version":"3.53.1"},"reference-count":74,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"11","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Glob Oncol"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>To develop a Latin American expert consensus to support, guide, and accelerate the approval and equitable access to anti-GD2 immunotherapy for patients with high-risk neuroblastoma (HR-NB) in the region. Survival rates for HR-NB have improved with the incorporation of anti-GD2 immunotherapy; however, despite the approval of two commercial anti-GD2 therapies in two countries, access remains limited in Latin America.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS AND RESULTS<\/jats:title>\n                    <jats:p>A systematic review was conducted of studies published from January 2004 through February 2025. Of 401 studies identified, 29 met inclusion criteria and served as the basis for four expert consensus statements on the use of anti-GD2 immunotherapy: (1) Newly diagnosed HR-NB maintenance therapy: Anti-GD2 immunotherapy as maintenance treatment for all newly diagnosed HR-NB patients is strongly recommended to maximize event-free survival and reduce the need for morbid and costly salvage therapies. (2) Relapsed\/refractory NB: Early integration (at first relapse) of anti-GD2 immunotherapy in salvage treatment is recommended. (3) Role of high-dose chemotherapy with autologous stem-cell transplant (ASCT): Some argue that anti-GD2 immunotherapy obviates the need for ASCT. However, until results of randomized trials omitting ASCT are available, the panel recommends continued use of ASCT where it is available. (4) Newly diagnosed HR-NB: incorporation of anti-GD2 during induction\/consolidation: Pilot studies using early anti-GD2 immunotherapy plus chemotherapy showed promising results but is not recommended until confirmed by larger studies with well-defined control arms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>This consensus highlights the urgent need to expand access to anti-GD2 therapy in Latin America as maintenance therapy for newly diagnosed patients with HR-NB and patients with relapsed or refractory neuroblastoma. Collaboration between health policymakers, the pharmaceutical industry, the Global Platform for Access to Childhood Cancer Medicines, and the pediatric oncology community is essential to address this challenge.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/go-25-00201","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T20:58:26Z","timestamp":1766523506000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":1,"title":["Latin American Consensus on the Use of Anti-GD2 Monoclonal Antibody Therapy in Patients With High-Risk Neuroblastoma"],"prefix":"10.1200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6159-1882","authenticated-orcid":true,"given":"Gabriela I.","family":"Villanueva","sequence":"first","affiliation":[{"name":"Hospital de Cl\u00ednicas Jos\u00e9 de San Martin, Ciudad Aut\u00f3noma de Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Alarc\u00f3n","sequence":"additional","affiliation":[{"name":"Departamento de Oncolog\u00eda Pedi\u00e1trica, Instituto Nacional de Enfermedades Neopl\u00e1sicas, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Bonilla","sequence":"additional","affiliation":[{"name":"Hospital Francisco Icaza Bustamante, Guayaquil, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6518-2050","authenticated-orcid":true,"given":"Alejandra","family":"Casanovas","sequence":"additional","affiliation":[{"name":"Hospital General de Ni\u00f1os Dr Pedro Elizalde, Servicio de Hematolog\u00eda y Oncolog\u00eda Infantil, Cuidad Aut\u00f3noma de Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1406-5801","authenticated-orcid":true,"given":"Mauricio","family":"Chaparro","sequence":"additional","affiliation":[{"name":"Hospital Pedi\u00e1trico de la Misericordia Fundaci\u00f3n HOMI, Bogot\u00e1, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0169-8522","authenticated-orcid":true,"given":"Marcelo D.","family":"Coirini","sequence":"additional","affiliation":[{"name":"Hospital de Ni\u00f1os V\u00edctor J. Vilela, Servicio de Oncolog\u00eda, Rosario, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0240-4311","authenticated-orcid":true,"given":"Guido","family":"Felizzia","sequence":"additional","affiliation":[{"name":"Departamento de Oncolog\u00eda Pedi\u00e1trica, Hospital Professor Dr Juan Garrahan, Cuidad Aut\u00f3noma de Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Figueredo","sequence":"additional","affiliation":[{"name":"Hospital de Cl\u00ednicas Facultad de Ciencias M\u00e9dicas, Universidad Nacional de Asunci\u00f3n, Asunci\u00f3n, Paraguay"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soad","family":"Fuentes-Alabi","sequence":"additional","affiliation":[{"name":"Hospital Nacional de Ni\u00f1os Benjamin Bloom y Centro M\u00e9dico Fundaci\u00f3n Ay\u00fadame a Vivir Pro- Ni\u00f1os con C\u00e1ncer de El Salvador, San Salvador, El Salvador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7076-6779","authenticated-orcid":true,"given":"Sima","family":"Ferman","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Cancer, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Franco","sequence":"additional","affiliation":[{"name":"Hospital da Crian\u00e7a de Bras\u00edlia e Hospital Bras\u00edlia, Bras\u00edlia, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Garcia Lombardi","sequence":"additional","affiliation":[{"name":"Hospital de Ni\u00f1os Ricardo Guti\u00e9rrez, Servicio de Oncolog\u00eda Pedi\u00e1trica, Cuidad Aut\u00f3noma de Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e9lix","family":"Gaytan Morales","sequence":"additional","affiliation":[{"name":"Hospital Infantil de M\u00e9xico Federico Gomez, Servicio de Trasplante de M\u00e9dula \u00d3sea, Ciudad de M\u00e9xico, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0788-7858","authenticated-orcid":true,"given":"Lauro J.","family":"Gregianin","sequence":"additional","affiliation":[{"name":"Hospital de Clinicas de Porto Alegre, Servi\u00e7o de Oncologia Pedi\u00e1trica, Porto Alegre, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9669-2632","authenticated-orcid":true,"given":"\u00d3scar","family":"Gonz\u00e1lez Ramella","sequence":"additional","affiliation":[{"name":"Hospital Civil de Guadalajara Dr Juan I Menchaca, Servicio de Hematolog\u00eda y Oncolog\u00eda Pedi\u00e1trica, Guadalajara, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalia","family":"Halley","sequence":"additional","affiliation":[{"name":"Hospital Israelita Albert Einstein, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Departamento de Oncologia Pedi\u00e1trica, Hospital do Santa Marcelina Sa\u00fade\/TUCCA, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arissa","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Cancer, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Howard","sequence":"additional","affiliation":[{"name":"Hospital Sant Joan de Deu Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9246-7884","authenticated-orcid":true,"given":"Luis E.","family":"Ju\u00e1rez Villegas","sequence":"additional","affiliation":[{"name":"Hospital Infantil de M\u00e9xico Federico G\u00f3mez, M\u00e9xico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3864-8967","authenticated-orcid":true,"given":"Fabiana","family":"Morosini","sequence":"additional","affiliation":[{"name":"Hospital Pereira Rossell, Servicio de Hemato Oncologia Pedi\u00e1trica, Fundaci\u00f3n P\u00e9rez Scremini, Montevideo, Uruguay"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1506-6753","authenticated-orcid":true,"given":"Alberto","family":"Olaya Vargas","sequence":"additional","affiliation":[{"name":"Departamento de Trasplante de C\u00e9lulas Hematopoy\u00e9ticas y Terapia Celular, Instituto Nacional de Pediatr\u00eda\/Centro M\u00e9dico ABC, Cuidad de M\u00e9xico, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Odone-Filho","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Children's Institute of the Hospital das Cl\u00ednicas de S\u00e3o Paulo ITACI, Sao Pablo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0566-1484","authenticated-orcid":true,"given":"Nevicolino","family":"Pereira de Carvalho Filho","sequence":"additional","affiliation":[{"name":"Departamento de Oncologia Pedi\u00e1trica, Hospital do Santa Marcelina Sa\u00fade\/TUCCA, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Peters","sequence":"additional","affiliation":[{"name":"Cl\u00ednica las Condes, Santiago de Chile, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"P\u00e9rez","sequence":"additional","affiliation":[{"name":"Hospital Roberto del Rio, Servicio de Oncolog\u00eda, Santiago de Chile, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mart\u00edn","family":"P\u00e9rez Garc\u00eda","sequence":"additional","affiliation":[{"name":"Comisi\u00f3n Coordinadora Institutos Nacionales de Salud y Hospitales de Alta Especialidad (CCINSHAE), Cuidad de M\u00e9xico, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agustina","family":"Pollono","sequence":"additional","affiliation":[{"name":"Hospital Interzonal de Agudos Especializado en Pediatr\u00eda (HIAEP) Sor Mar\u00eda Ludovica, Sala de Oncolog\u00eda, La Plata, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6883-2606","authenticated-orcid":true,"given":"Roy","family":"Rosado","sequence":"additional","affiliation":[{"name":"Unidad Nacional de Oncolog\u00eda Pedi\u00e1trica, Guatemala, Guatemala"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6450-1638","authenticated-orcid":true,"given":"Lourdes","family":"Romero","sequence":"additional","affiliation":[{"name":"Hospital Infantil Telet\u00f3n de Oncolog\u00eda, Quer\u00e9taro, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8107-6629","authenticated-orcid":true,"given":"Hayde\u00e9 del Pilar","family":"Salazar Rosales","sequence":"additional","affiliation":[{"name":"Departamento de Trasplante de C\u00e9lulas Hematopoy\u00e9ticas y Terapia Celular, Instituto Nacional de Pediatr\u00eda, Cuidad de M\u00e9xico, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Silva","sequence":"additional","affiliation":[{"name":"Hospital Luis Calvo Mackenna, Unidad de Oncolog\u00eda, Santiago de Chile, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Sobrero","sequence":"additional","affiliation":[{"name":"Hospital Zonal Dr Ram\u00f3n Carrillo\u2014Sanatorio San Carlos, San Carlos de Bariloche, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delia P.","family":"Streitenberger","sequence":"additional","affiliation":[{"name":"Hospital Italiano De Buenos Aires. Servicio de Hematolog\u00eda-Oncolog\u00eda Pedi\u00e1trica, Cuidad Aut\u00f3noma de Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Valencia","sequence":"additional","affiliation":[{"name":"Imat Oncomedica Auna, Hospital Universitario de Santander, Santander, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Varela","sequence":"additional","affiliation":[{"name":"Departamento de Oncologia Pedi\u00e1trica, Hospital Austral, Pilar, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Villarroel","sequence":"additional","affiliation":[{"name":"Hospital Luis Calvo Mackenna, Unidad de Oncolog\u00eda, Santiago de Chile, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2014.09.015"},{"key":"e_1_3_7_3_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.0421"},{"key":"e_1_3_7_4_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00919"},{"key":"e_1_3_7_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.78"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25501"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.11642"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.575009"},{"key":"e_1_3_7_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0911123"},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02478"},{"key":"e_1_3_7_11_2","volume-title":"Drug Trials Snapshots: UNITUXIN","author":"US Food and Drug Administration","year":"2019","unstructured":"US Food and Drug Administration: Drug Trials Snapshots: UNITUXIN. 2019. https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/drug-trials-snapshots-unituxin"},{"key":"e_1_3_7_12_2","unstructured":"US Food and Drug Administration: Research C for DE and FDA grants accelerated approval to naxitamab for high-risk neuroblastoma in bone or bone marrow. 2021. https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-accelerated-approval-naxitamab-high-risk-neuroblastoma-bone-or-bone-marrow"},{"key":"e_1_3_7_13_2","volume-title":"Qarziba (Previously Dinutuximab Beta EUSA and Dinutuximab Beta Apeiron)","author":"European Medicines Agency","year":"2017","unstructured":"European Medicines Agency: Qarziba (Previously Dinutuximab Beta EUSA and Dinutuximab Beta Apeiron). EMA. 2017. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/qarziba-previously-dinutuximab-beta-eusa-dinutuximab-beta-apeiron"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28273"},{"key":"e_1_3_7_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-017-2379-5"},{"key":"e_1_3_7_16_2","doi-asserted-by":"publisher","DOI":"10.4103\/0973-1482.183205"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27944"},{"key":"e_1_3_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2014.03.017"},{"key":"e_1_3_7_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-018-2834-6"},{"key":"e_1_3_7_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mph.0000199601.35010.52"},{"key":"e_1_3_7_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20219"},{"key":"e_1_3_7_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"e_1_3_7_23_2","unstructured":"Risk of bias tools: Current version of RoB 2. https:\/\/www.riskofbias.info\/welcome\/rob-2-0-tool\/current-version-of-rob-2"},{"key":"e_1_3_7_24_2","unstructured":"Risk of bias tools: ROBINS-I V2 tool. https:\/\/www.riskofbias.info\/welcome\/robins-i-v2"},{"key":"e_1_3_7_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29568"},{"key":"e_1_3_7_26_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.10003"},{"key":"e_1_3_7_27_2","article-title":"Phase II clinical trial with long-term infusion of anti-GD2 antibody ch14.18\/CHO in combination with interleukin-2 (IL2) in patients with high risk neuroblastoma","volume":"34","author":"Lode HN","year":"2016","unstructured":"Lode HN, Valteau-Couanet D, Troschke-Meurer S, et al: Phase II clinical trial with long-term infusion of anti-GD2 antibody ch14.18\/CHO in combination with interleukin-2 (IL2) in patients with high risk neuroblastoma. J Clin Oncol 34, 2016 (suppl 15; abstr 10562)","journal-title":"J Clin Oncol"},{"key":"e_1_3_7_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12868"},{"key":"e_1_3_7_29_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.6393"},{"key":"e_1_3_7_30_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-836518"},{"key":"e_1_3_7_31_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-3909"},{"key":"e_1_3_7_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30578-3"},{"key":"e_1_3_7_33_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.35.15_suppl.10534"},{"key":"e_1_3_7_34_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01375"},{"key":"e_1_3_7_35_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-21"},{"key":"e_1_3_7_36_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.41.3807"},{"key":"e_1_3_7_37_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020309"},{"key":"e_1_3_7_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29121"},{"key":"e_1_3_7_39_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01273"},{"key":"e_1_3_7_40_2","doi-asserted-by":"publisher","unstructured":"Relapsed\/refractory neuroblastoma patients respond to anti GD2 antibody ch14.18\/CHO delivered by long-term infusion combined with interleukin-2 and show improved survival rates compared to historical controls. SIOP 2015 Scientific Programme + Index. Pediatr Blood Cancer 62. 10.1002\/pbc.25715","DOI":"10.1002\/pbc.25715"},{"key":"e_1_3_7_41_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1082771"},{"key":"e_1_3_7_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30355-8"},{"key":"e_1_3_7_43_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00203"},{"key":"e_1_3_7_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-023-02457-x"},{"key":"e_1_3_7_45_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.8861"},{"key":"e_1_3_7_46_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.10014"},{"key":"e_1_3_7_47_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.10002"},{"key":"e_1_3_7_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.114001"},{"key":"e_1_3_7_49_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01630"},{"key":"e_1_3_7_50_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.10028"},{"key":"e_1_3_7_51_2","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2017.1402997"},{"key":"e_1_3_7_52_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56619-x"},{"key":"e_1_3_7_53_2","volume-title":"Registro Oncopediatrico Argentino. Tendencia de incidencia 2000-2019, Superviviencia a 5 a\u00f1os 2005-2014, Tendencia de superviviencia secular: 2000-05, 2006-11, 2012-16","author":"Instituto Nacional del Cancer","unstructured":"Instituto Nacional del Cancer: Registro Oncopediatrico Argentino. Tendencia de incidencia 2000-2019, Superviviencia a 5 a\u00f1os 2005-2014, Tendencia de superviviencia secular: 2000-05, 2006-11, 2012-16. https:\/\/www.argentina.gob.ar\/sites\/default\/files\/bancos\/2022-07\/07-22-Registro-oncopedi%C3%A1trico-argentino.pdf"},{"key":"e_1_3_7_54_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25987"},{"key":"e_1_3_7_55_2","doi-asserted-by":"publisher","DOI":"10.26633\/RPSP.2024.38"},{"key":"e_1_3_7_56_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24799"},{"key":"e_1_3_7_57_2","first-page":"1302","article-title":"Treatment of high-risk neuroblastoma","volume":"10","author":"Krystal J","year":"2023","unstructured":"Krystal J, Foster JH: Treatment of high-risk neuroblastoma. Children (Basel) 10:1302, 2023","journal-title":"Children (Basel)"},{"key":"e_1_3_7_58_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13194941"},{"key":"e_1_3_7_59_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17010149"},{"key":"e_1_3_7_60_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26244"},{"key":"e_1_3_7_61_2","doi-asserted-by":"publisher","DOI":"10.32635\/2176-9745.RBC.2018v64n1.111"},{"key":"e_1_3_7_62_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15143729"},{"key":"e_1_3_7_63_2","volume-title":"ISPOR | International Society For Pharmacoeconomics and Outcomes Research. Budget Impact and Cost-Utility Analysis of Naxitamab plus GM-CSF for the Treatment of Refractory\/Relapsed HR-NB in the Brazilian Private Healthcare Population","author":"Holko","year":"2025","unstructured":"Holko: ISPOR | International Society For Pharmacoeconomics and Outcomes Research. Budget Impact and Cost-Utility Analysis of Naxitamab plus GM-CSF for the Treatment of Refractory\/Relapsed HR-NB in the Brazilian Private Healthcare Population. ISPOR; Value in Health, Volume 28, Issue S1. 2025. https:\/\/www.ispor.org\/conferences-education\/conferences\/past-conferences\/ispor-europe-2024\/program\/program\/session\/euro2024-4015\/141758?utm"},{"key":"e_1_3_7_64_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-022-00930-w"},{"key":"e_1_3_7_65_2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.7045"},{"key":"e_1_3_7_66_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1164949"},{"key":"e_1_3_7_67_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26192"},{"key":"e_1_3_7_68_2","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1016704"},{"key":"e_1_3_7_69_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-2000"},{"key":"e_1_3_7_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2019.11.011"},{"key":"e_1_3_7_71_2","doi-asserted-by":"publisher","DOI":"10.1179\/102453312X13336169157059"},{"key":"e_1_3_7_72_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.4492.4492"},{"key":"e_1_3_7_73_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-1452"},{"key":"e_1_3_7_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2017.07.011"},{"key":"e_1_3_7_75_2","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000001992"}],"container-title":["JCO Global Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/GO-25-00201","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T20:58:37Z","timestamp":1766523517000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/GO-25-00201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":74,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1200\/GO-25-00201"],"URL":"https:\/\/doi.org\/10.1200\/go-25-00201","relation":{},"ISSN":["2687-8941"],"issn-type":[{"value":"2687-8941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"2025-04-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2500201"}}